Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan B Dreyer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scottish Medical Journal|November 23, 2014
Ruptured abdominal aortic aneurysms: decreasing incidence may reduce the impact of a Scottish screening programmeStephan B Dreyer, Paul Burns
Nature Reviews. Clinical Oncology|May 6, 2025
Improving outcomes of patients with pancreatic cancerStephan B Dreyer, Philip Beer, Sunil R Hingorani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic DevelopmentStephan B Dreyer, David K Chang, Peter Bailey, et al.
Cancers|November 11, 2022
Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic CancerAdam S Bryce, Stephan B Dreyer, Fieke E M Froeling, et al.
Annals of Surgical Oncology|November 23, 2016
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerStephan B Dreyer, Arfon G M T Powell, Stephen T McSorley, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Annals of Surgery|July 18, 2020
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic CancerStephan B Dreyer, Mark Pinese, Nigel B Jamieson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scottish Medical Journal|November 23, 2014
Ruptured abdominal aortic aneurysms: decreasing incidence may reduce the impact of a Scottish screening programmeStephan B Dreyer, Paul Burns
Nature Reviews. Clinical Oncology|May 6, 2025
Improving outcomes of patients with pancreatic cancerStephan B Dreyer, Philip Beer, Sunil R Hingorani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic DevelopmentStephan B Dreyer, David K Chang, Peter Bailey, et al.
Cancers|November 11, 2022
Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic CancerAdam S Bryce, Stephan B Dreyer, Fieke E M Froeling, et al.
Annals of Surgical Oncology|November 23, 2016
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal CancerStephan B Dreyer, Arfon G M T Powell, Stephen T McSorley, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Annals of Surgery|July 18, 2020
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic CancerStephan B Dreyer, Mark Pinese, Nigel B Jamieson, et al.
Pageof 2